BIOMAT Database Logo BIOMAT Database Logo

Photodynamic inactivation of simian immunodeficiency virus. 1989

T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78284.

A photodynamic flow system employing a dihematoporphyrin ether (DHE) was tested for its ability to inactivate the in vitro infectivity of simian immunodeficiency virus (SICMac) at 630 +/- 5 nm with a light fluence of 5 J/cm2. Cell-free SIVMac was inactivated by photoactivated hematoporphyrin derivative in a dose-dependent fashion. Since SIVMac is closely related to human immunodeficiency virus type 2 (HIV-2) and we have previously reported the successful photodynamic inactivation of HIV-1 in cell-free medium as well as in whole human blood, this technology has the potential for the eradication of transfusion-associated acquired immunodeficiency diseases caused by the above-mentioned retroviruses.

UI MeSH Term Description Entries
D008027 Light That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range. Light, Visible,Photoradiation,Radiation, Visible,Visible Radiation,Photoradiations,Radiations, Visible,Visible Light,Visible Radiations
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D010777 Photochemistry A branch of physical chemistry which studies chemical reactions, isomerization and physical behavior that may occur under the influence of visible and/or ultraviolet light. Photochemistries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006415 Hematoporphyrins Iron-free derivatives of heme with 4 methyl groups, 2 hydroxyethyl groups and 2 propionic acid groups attached to the pyrrole rings. Some of these PHOTOSENSITIZING AGENTS are used in the PHOTOTHERAPY of malignant NEOPLASMS. Haematoporphyrin IX,Hematoporphyrin,Hemedonin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D017323 Dihematoporphyrin Ether The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States. DHP Ether,Porfimer,Dihematoporphyrin Ester,Photofrin,Photofrin II,Porfimer Sodium,Ether, Dihematoporphyrin

Related Publications

T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Inactivation of simian immunodeficiency virus by hydrostatic pressure.
July 1995, Proceedings of the National Academy of Sciences of the United States of America,
T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections.
January 1997, AIDS (London, England),
T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Simian immunodeficiency virus pathogenesis.
January 2009, Current HIV research,
T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Coreceptors for human immunodeficiency virus and simian immunodeficiency virus.
January 2000, Advances in pharmacology (San Diego, Calif.),
T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Photodynamic inactivation of rubella virus.
November 1972, Journal of medical microbiology,
T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Photodynamic inactivation of Junin virus.
January 1986, Medical microbiology and immunology,
T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Estimating the impact of vaccination on acute simian-human immunodeficiency virus/simian immunodeficiency virus infections.
December 2008, Journal of virology,
T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Simian immunodeficiency virus in people.
January 1994, The New England journal of medicine,
T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Nonpathogenic simian immunodeficiency virus infections.
January 2012, Cold Spring Harbor perspectives in medicine,
T C Chanh, and J S Allan, and J L Matthews, and F Sogandares-Bernal, and M M Judy, and H Skiles, and J Leveson, and A Marengo-Rowe, and J T Newman
Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections.
October 1998, Journal of virology,
Copied contents to your clipboard!